Scinai Immunotherapeutics Ltd. (SCNI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Scinai Immunotherapeutics...

    NASDAQ: SCNI · Real-Time Price · USD
    1.50
    -0.02 (-1.32%)
    At close: Sep 09, 2025, 12:32 PM

    Scinai Immunotherapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 658K n/a n/a n/a
    Cost of Revenue
    		 1.24M 512.67K 559.8K 747.65K
    Gross Profit
    		 -580K n/a n/a n/a
    Operating Income
    		 -8.64M -9.71M -11.06M -10.87M
    Interest Income
    		 100K 122.68K 8.1M 929.00
    Pretax Income
    		 4.8M -6.5M -5.8M -8.21M
    Net Income
    		 4.8M -6.5M -5.8M -8.21M
    Selling & General & Admin
    		 2.53M 4.5M 5.3M 7.63M
    Research & Development
    		 5.53M 5.21M 5.76M 3.25M
    Other Expenses
    		 n/a -9K n/a -12K
    Operating Expenses
    		 8.06M 9.18M 11.06M 10.05M
    Interest Expense
    		 1.44M 7.98K 5.05M 3.36M
    Selling & Marketing Expenses
    		 n/a n/a n/a -91.96K
    Cost & Expenses
    		 9.3M 9.71M 11.06M 10.87M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 806.37K 390.66K 188.52K 102.57K
    Shares Outstanding (Diluted)
    		 806.37K 390.66K 188.52K 141.14K
    EPS (Basic)
    		 5.95 -66.56K -122.96K -232.56K
    EPS (Diluted)
    		 5.95 -66.56K -122.96K -320K
    EBITDA
    		 7.87M -9.19M -10.5M -10.39M
    EBIT
    		 6.22M -9.71M -11.06M -10.86M
    Depreciation & Amortization
    		 1.65M 514K 562K 471K

    Add to Watchlist